Yan Liu

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

Medicine, Molecular Genetics, Oncology +15

EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

Wendy Béguelin, Relja Popovic, Matt Teater et al. · Cancer Cell · 2013 · 841 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC

Helai P. Mohammad, Kimberly N. Smitheman, Chandrashekhar D. Kamat et al. · Cancer Cell · 2015 · 512 citations · Full text

Medicine, Molecular Biology, Oncology +12

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Ende Zhao, Tomasz Maj, Ilona Kryczek et al. · Nature Immunology · 2015 · 405 citations

Medicine, Molecular Biology, Oncology +14

Activation of the <i>NOTCH</i> Pathway in Head and Neck Cancer

Wenyue Sun, Daria A. Gaykalova, Michael F. Ochs et al. · Cancer Research · 2013 · 199 citations

Medicine, Molecular Genetics, Oncology +17